Section of Aging & Dementia

Division of Adult Neurology

adult memory, aging, alzheimers, dementia, neurodegenerative, mild cognitive impairment, frontotemporal dementia

Patient care

Memory Diagnostic Center

Our team

Showing: All results
Andrew  Aschenbrenner, PhD

Andrew Aschenbrenner, PhD

Assistant Professor of Neurology

Ganesh  Babulal, PhD

Ganesh Babulal, PhD

Associate Professor of Neurology
Aging and Dementia

Joyce Balls-Berry, PhD

Joyce Balls-Berry, PhD

Associate Professor of Neurology

  Balls-Berry lab

Randall  Bateman, MD

Randall Bateman, MD

Charles F. & Joanne Knight Distinguished Professor of Neurology
Adult, Aging & Dementia
Director of the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU)


  Bateman lab

 
Top areas of adult care: Alzheimer’s disease, dementia, geriatric neurology
Michael Belloy, PhD

Michael Belloy, PhD

Assistant Professor of Neurology, Aging & Dementia
Assistant Professor of Psychiatry

John  Cirrito, PhD

John Cirrito, PhD

Professor of Neurology

  Cirrito lab

Andrea  Denny, JS, MSSW

Andrea Denny, JS, MSSW

Instructor in Neurology

Anne  Fagan , PhD

Anne Fagan , PhD

Professor of Neurology

Gilbert  Gallardo, PhD

Gilbert Gallardo, PhD

Assistant Professor of Neurology

  Gallardo lab

Jee-young Han, MD, MSC

Jee-young Han, MD, MSC

Assistant Professor of Neurology
Adult, Aging & Dementia

 
Top areas of adult care: frontotemporal dementia, Alzheimer’s disease, memory loss
Jason  Hassenstab, PhD

Jason Hassenstab, PhD

Associate Professor, Neurology

David  Holtzman, MD

David Holtzman, MD

Barbara Burton & Reuben M. Morriss III Distinguished Professor of Neurology, Adult, Aging & Dementia
Scientific Director, Hope Center for Neurological Disorders
Director, Knight Alzheimer’s Disease Research Center
Professor of Developmental Biology


  Holtzman lab

 
Top areas of adult care: Alzheimer’s disease, Lewy body dementia, frontotemporal dementia

Research

Knight Alzheimer Disease Research Center

Conducting internationally recognized research in Alzheimer disease research

Recent publications

  • Characteristics of discordance between amyloid positron emission tomography and plasma amyloid-β 42/40 positivityPyun, J. M., Park, Y. H., Youn, Y. C., Kang, M. J., Shim, K. H., Jang, J. W., You, J., Nho, K., Kim, S. Y., Weiner, M. W., Aisen, P., Petersen, R., Jack, C. R., Jagust, W., Trojanowki, J. Q., Toga, A. W., Beckett, L., Green, R. C., Saykin, A. J. & Morris, J. & 63 others, Shaw, L. M., Sorensen, G., Carrillo, M., Kuller, L., Raichle, M., Paul, S., Davies, P., Fillit, H., Hefti, F., Holtzman, D., Mesulam, M. M., Potter, W., Snyder, P., Hendrix, J., Vasanthakumar, […]
  • Genetic and multi-omic resources for Alzheimer disease and related dementia from the Knight Alzheimer Disease Research CenterFernandez, M. V., Liu, M., Beric, A., Johnson, M., Cetin, A., Patel, M., Budde, J., Kohlfeld, P., Bergmann, K., Lowery, J., Flynn, A., Brock, W., Sanchez Montejo, B., Gentsch, J., Sykora, N., Norton, J., Gentsch, J., Valdez, O., Gorijala, P. & Sanford, J. & 24 others, Sun, Y., Wang, C., Western, D., Timsina, J., Mangetti Goncalves, T., Do, A. N., Sung, Y. J., Zhao, G., Morris, J. C., Moulder, K., Holtzman, D. M., Bateman, R. J., Karch, C., Hassenstab, J., Xiong, C., Schindler, S. […]
  • Baseline levels and longitudinal changes in plasma Aβ42/40 among Black and white individualsXiong, C., Luo, J., Wolk, D. A., Shaw, L. M., Roberson, E. D., Murchison, C. F., Henson, R. L., Benzinger, T. L. S., Bui, Q., Agboola, F., Grant, E., Gremminger, E. N., Moulder, K. L., Geldmacher, D. S., Clay, O. J., Babulal, G., Cruchaga, C., Holtzman, D. M., Bateman, R. J. & Morris, J. C. & 1 others, Schindler, S. E., Dec 2024, In: Nature communications. 15, 1, 5539.Research output: Contribution to journal › Article › peer-review
  • Inter-continental variability in the relationship of oxidative potential and cytotoxicity with PM2.5 massSalana, S., Yu, H., Dai, Z., Subramanian, P. S. G., Puthussery, J. V., Wang, Y., Singh, A., Pope, F. D., Leiva G, M. A., Rastogi, N., Tripathi, S. N., Weber, R. J. & Verma, V., Dec 2024, In: Nature communications. 15, 1, 5263.Research output: Contribution to journal › Article › peer-review
  • A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of Posiphen in subjects with early Alzheimer’s DiseaseGalasko, D., Farlow, M. R., Lucey, B. P., Honig, L. S., Elbert, D., Bateman, R., Momper, J., Thomas, R. G., Rissman, R. A., Pa, J., Aslanyan, V., Balasubramanian, A., West, T., Maccecchini, M. & Feldman, H. H., Dec 2024, In: Alzheimer's Research and Therapy. 16, 1, 151.Research output: Contribution to journal › Article › peer-review

Contact us

Leadership

John C. Morris, MD
Director, Section of Aging and Dementia
Professor of Neurology

Patient Appointments

Voice: 314-286-1967